Key points are not available for this paper at this time.
Abstract Background Persistent innate and adaptive immune responses in the brain contribute to the progression of Alzheimer’s disease (AD). APOE4 , the most important genetic risk factor for sporadic AD, encodes apolipoprotein E4, which by itself is a potent modulator of immune response. However, little is known about the immune hub that governs the crosstalk between the nervous and the adaptive immune systems. Transient receptor potential vanilloid type 1 (TRPV1) channel is a ligand-gated, nonselective cation channel with Ca 2+ permeability, which has been proposed as a neuroprotective target in AD. Methods Using Ca 2+ -sensitive dyes, dynamic changes of Ca 2+ in microglia were measured, including exogenous Ca 2+ uptake and endoplasmic reticulum Ca 2+ release. The mRFP-GFP-tagged LC3 plasmid was expressed in microglia to characterize the role of TRPV1 in the autophagic flux. Transcriptomic analyses and flow cytometry were performed to investigate the effects of APOE4 on brain microglia and T cells from APOE -targeted replacement mice with microglia-specific TRPV1 gene deficiency. Results Both APOE4 microglia derived from induced pluripotent stem cells of AD patients and APOE4 -related tauopathy mouse model showed significantly increased cholesterol biosynthesis and accumulation compared to their APOE3 counterparts. Further, cholesterol dysregulation was associated with persistent activation of microglia and elevation of major histocompatibility complex II-dependent antigen presentation in microglia, subsequently accompanied by T cell infiltration. In addition, TRPV1-mediated transient Ca 2+ influx mitigated cholesterol biosynthesis in microglia by suppressing the transcriptional activation of sterol regulatory element-binding protein 2, promoted autophagic activity and reduced lysosomal cholesterol accumulation, which were sufficient to resolve excessive immune response and neurodegeneration in APOE4 -related tauopathy mouse model. Moreover, microglia-specific deficiency of TRPV1 gene accelerated glial inflammation, T cell response and associated neurodegeneration in an APOE4 -related tauopathy mouse model. Conclusions The findings provide new perspectives for the treatment of APOE4 -dependent neurodegeneration including AD.
Lu et al. (Tue,) studied this question.